Nvidia-Backed Recursion, Ginkgo Bioworks Rally Following FDA's Decision To End Animal Testing FDA announces plan to end mandatory animal testing of new drugs, replacing it with more effective and human relevant methods.
Health Care Technology Stocks Surge After FDA Announces Plans To Phase Out Animal Testing Requirements Several stocks in the health care technology space are moving higher after the market close on Thursday after the U.S. Food and Drug Administration (FDA) announced plans to phase out animal testing requirements.
Which Healthcare Stock Is the Best Buy Right Now? Healthcare stocks provide a combination of upstarts with a high risk, high reward proposition to established firms that can be a defensive maneuver.
Cathie Wood-Led Ark Invest Roblox, Roku, UiPath As Markets Take A Dip Ark Invest made significant trades on Friday, selling shares of RBLX, ROKU, PATH and buying shares of IBTA, PSNL, ABSI, and RXRX.
What's going on in today's after hours session Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.
Analyst Praises AMD-Partner Absci's Practical Approach, Sees 118% Stock Upside Needham initiated a Buy rating for Absci (ABSI), noting its AI-powered drug discovery platforms, strategic partnerships, and $9 price target.
Cathie Wood's Ark Invest Buys Into Defense And Energy Stocks Amid Trump's Inaugural Policies Cathie Wood-led Ark Invest made significant trades involving ACCD, DE, NTLA, PATH, CCJ, OKLO, ILMN, ESLT, and ABSI.
Absci Stock Jumps As AMD Invests $20M To Boost AI Drug Discovery Absci shares are rising after announcing a strategic collaboration with Advanced Micro Devices Inc. The partnership will enhance Absci's AI drug discovery capabilities using AMD Instinct accelerators and ROCm software.
